Synchron is developing electronic devices that aims to help people with paralysis control their body, and the brain-computer interface (BCI) company has big ambitions…
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…
Vaxxinity’s beta-amyloid vaccine to treat Alzheimer’s disease — UB-311 — recently received fast track designation as it finishes up Phase 2 trials. Image: Vaxxinity…
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
The Food and Drug Administration issued an update to Aduhelm’s label, now requiring a total of four MRIs during the first year of treatment…
Biogen has withdrawn the application anti-amyloid Alzheimer’s drug Aduhelm from Europe’s regulatory agency. Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s…
Scientists are exploring the role of tau tangles in Alzheimer’s, and whether addressing these misfolded proteins could treat the disease. Here’s what you need…